These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7589429)

  • 1. Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex.
    Schreuder H; Tardif C; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
    FEBS Lett; 1995 Oct; 373(1):39-40. PubMed ID: 7589429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
    Schreuder H; Tardif C; Trump-Kallmeyer S; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
    Nature; 1997 Mar; 386(6621):194-200. PubMed ID: 9062194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors.
    Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T
    Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational dynamics and kinetics of peptide antagonist interactions with interleukin-1 receptor. Fluorescence studies using the NBD-labelled peptide AF12415.
    Cowley DJ; Schulze AJ
    J Pept Res; 1997 May; 49(5):444-54. PubMed ID: 9211226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production and characterization of a modified recombinant interleukin-1 receptor antagonist.
    Chang DM; Chou WY
    Immunol Invest; 1996 Jul; 25(4):355-68. PubMed ID: 8805056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential.
    Lauffer L; Kanzy EJ; Köhler R; Kurrle R; Enssle K; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):21-31. PubMed ID: 7575349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of human interleukin-1 receptor antagonist protein.
    Stockman BJ; Scahill TA; Strakalaitis NA; Brunner DP; Yem AW; Deibel MR
    FEBS Lett; 1994 Jul; 349(1):79-83. PubMed ID: 8045306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.
    Schreuder HA; Rondeau JM; Tardif C; Soffientini A; Sarubbi E; Akeson A; Bowlin TL; Yanofsky S; Barrett RW
    Eur J Biochem; 1995 Feb; 227(3):838-47. PubMed ID: 7867645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1.
    Vigers GP; Dripps DJ; Edwards CK; Brandhuber BJ
    J Biol Chem; 2000 Nov; 275(47):36927-33. PubMed ID: 10903327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid.
    Rochel N; Renaud JP; Ruff M; Vivat V; Granger F; Bonnier D; Lerouge T; Chambon P; Gronemeyer H; Moras D
    Biochem Biophys Res Commun; 1997 Jan; 230(2):293-6. PubMed ID: 9016769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
    Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
    Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of IL-1 activity by soluble IL-1 receptors.
    Kurrle R; Lauffer L; Röder J; Kanzy EJ; Enssle KH; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):45-57. PubMed ID: 7575352
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
    Symons JA; Young PR; Duff GW
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of an interleukin-1 intracellular receptor antagonist mRNA variant.
    Weissbach L; Tran K; Colquhoun SA; Champliaud MF; Towle CA
    Biochem Biophys Res Commun; 1998 Mar; 244(1):91-5. PubMed ID: 9514884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of equine interleukin 1 receptor antagonist and determination of its full-length cDNA sequence.
    Howard RD; McIlwraith CW; Trotter GW; Nyborg JK
    Am J Vet Res; 1998 Jun; 59(6):712-6. PubMed ID: 9622739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
    Raibekas AA; Bures EJ; Siska CC; Kohno T; Latypov RF; Kerwin BA
    Biochemistry; 2005 Jul; 44(29):9871-9. PubMed ID: 16026159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
    Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.